125I brachytherapy in locally advanced Non-Small Cell Lung Cancer after progression of concurrent ra

来源 :第四届广州国际肿瘤学会议 | 被引量 : 0次 | 上传用户:scuthh
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Purpose: To investigate the safety and effectiveness of computed tomography(CT)-guided 125I seed implantation for locally advanced non-small cell lung cancer(NSCLC)after progression of concurrent radiochemotherapy(CCRT).
其他文献
Objective: To compare and analyze the clinical efficacy of large hepatocellular carcinoma more than 5cm between multi-electrode synchronous radiofrequency ablation via switching controller with transc
Purpose: To investigate the role of ERK kinase and exportin-5(XPO5)phosphorylation on miRNA expression in hepatocellular carcinoma(HCC).
Despite tremendous progress in diagnosis and treatments of nasopharyngeal carcinoma(NPC)has been achieved nowadays,distant metastasis remains one of the major cause of death,leading to a grim prognosi
会议
Objective: To study the effects of different electrode exposed end and different ablated time on lesion size of Cool-tipmulti-electrodesynchronousradiofrequency ablation via switching controller in ex
Purpose: To assess the effectiveness of early treatment of small pulmonary nodules with the size of 20mm or less by video-assisted thoracoscopic surgery(VATS)combined with preoperative computed tomogr
会议
PURPOSE: To prospectively evaluate the feasibility and clinical value of computed tomography(CT)-guided 125I brachytherapy in treating bilateral lung recurrences from colorectal carcinoma.
Background: Inflammation-based prognosis using the Glasgow Prognostic Score(GPS)is an established prognostic factor for several types of malignancies.
会议
Nasopharyngeal carcinoma(NPC)is an endemic public health problem in South and Southeast Asian countries.
Purpose We investigated implanting computed tomography(CT)-guided 125I seed to treat locally advanced non-small-cell lung cancer(NSCLC)after chemotherapy failure.
Liver transplantation(LT)has become a curative treatment for patients with hepatocellular carcinoma(HCC).